Recipharm AB operates as a pharmaceutical contract development and manufacturing company. Its dosage forms include solid dose, steriles, semi solids, beta-lactams, hormones, dry powder inhalers, granulates, and powders. The company provides pharmaceutical development services, such as formulation development, clinical supplies, analytical development, stability studies, packaging development and selection, and raw material selection; and manufacturing services. It also offers EU gateway release and testing, regulatory, stability studies, and customized services. Recipharm AB was founded in 1995 and is based in Haninge, Sweden. It has manufacturing facilities in Sweden, France, and the United Kingdom.

2,638 (est)
Recipharm is headquartered in SE

Key People at Recipharm

Sture Nordberg

Sture Nordberg

Vice President of Science & Technology
Thomas Eldered

Thomas Eldered


Recipharm Locations

Recipharm Metrics

Recipharm Summary

Market capitalization

kr5650 B

Closing share price

Recipharm's latest market capitalization is kr5650 B.

Recipharm Market Value History

Recipharm Company Life